Last updated: May 15, 2018
Sponsor: Ain Shams University
Overall Status: Completed
Phase
2/3
Condition
Diabetes Mellitus, Type 2
Hypertriglyceridemia
Diabetes (Pediatric)
Treatment
N/AClinical Study ID
NCT03437902
PHCL39
Ages > 35 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
• Patients' age 35 years or older having type 2 diabetes mellitus.
Patients taking oral diabetic medications (Sulfonylurea) not taking Insulin.
Able to understand and willing to sign a written informed consent document
Exclusion
Exclusion Criteria:
- • Pregnant and breast feeding females
• use of vitamin supplements containing vitamin C or other antioxidants.
patients with renal or hepatic failure.
patients taking insulin as antidiabetic treatment
Study Design
Total Participants: 53
Study Start date:
February 24, 2018
Estimated Completion Date:
May 15, 2018
Connect with a study center
Ain Shams University
Cairo,
EgyptSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.